Matsukawa Noriyuki, Ojika Kosei
Department of Neurology and Neuroscience, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467 8601 Japan.
Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Nov;26(5-6):219-27.
Based on the hypothesis of target-derived trophic factor, we have purified a novel peptide from young rat hippocampus, named Hippocampal Cholinergic Neurostimulating Peptide: HCNP, which induces the synthesis of acetylcholine in the medial septal nucleus. This peptide is aligned with the N terminal of protein composed 186 amino acids (HCNP precursor protein), and released from neurons in hippocampus by the NMDA receptor stimulation. Moreover, HCNP precursor can be involved in neural activity in hippocampus via the inhibition of phosphorylation of Erk. HCNP and its precursor can be a candidate for the key molecules elucidating the underlying association among Abeta, phosphorylated tau, degeneration of dendritic spine and decrease of acetylcholine in Alzheimer brain.
基于靶源性营养因子的假说,我们从幼鼠海马体中纯化出一种新型肽,命名为海马胆碱能神经刺激肽:HCNP,它能诱导内侧隔核中乙酰胆碱的合成。这种肽与由186个氨基酸组成的蛋白质(HCNP前体蛋白)的N端对齐,并通过NMDA受体刺激从海马体中的神经元释放出来。此外,HCNP前体可通过抑制Erk的磷酸化参与海马体中的神经活动。HCNP及其前体可能是阐明阿尔茨海默病大脑中β淀粉样蛋白、磷酸化tau蛋白、树突棘退化和乙酰胆碱减少之间潜在关联的关键分子候选物。